Luxembourg vs Micronesia, Federated States of: The number of people with susceptibility test result for rifampicin
Luxembourg
21
in 2021
Micronesia, Federated States of
27
in 2021
Luxembourg rank
132nd
Micronesia, Federated States of rank
129th
The number of people with susceptibility test result for rifampicin over time
- Luxembourg
- Micronesia, Federated States of
How they compare
Micronesia, Federated States of currently reports 27 against 21 in Luxembourg, a difference of 6.
That makes Micronesia, Federated States of's figure about 1.3 times Luxembourg's.
Across all 5 years both countries report, Micronesia, Federated States of has been ahead every year.
Luxembourg ranks 132nd and Micronesia, Federated States of ranks 129th of 155 countries.
Micronesia, Federated States of has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Luxembourg | Micronesia, Federated States of | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 5.33 | 32 | 26.67 | Micronesia, Federated States of |
| 2020s | 19.5 | 28 | 8.5 | Micronesia, Federated States of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Luxembourg or Micronesia, Federated States of?
- Micronesia, Federated States of, at 27 against 21 in Luxembourg as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Luxembourg and Micronesia, Federated States of?
- 6, with Micronesia, Federated States of ahead.
- How many years of comparable data are there for Luxembourg and Micronesia, Federated States of?
- 5 years are reported by both, from 2017 to 2021.
- How do Luxembourg and Micronesia, Federated States of rank globally for the number of people with susceptibility test result for rifampicin?
- Luxembourg ranks 132nd and Micronesia, Federated States of ranks 129th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.